These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38002025)

  • 121. Nicotinamide N-methyltransferase is related to MELF pattern invasion in endometrioid carcinoma.
    Tahara S; Nojima S; Ohshima K; Hori Y; Sato K; Kurashige M; Matsui T; Okuzaki D; Morii E
    Cancer Med; 2021 Dec; 10(23):8630-8640. PubMed ID: 34655178
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.
    Choi S; Kim SW; Kim HS
    Cancer Genomics Proteomics; 2021; 18(5):685-698. PubMed ID: 34479920
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 124. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.
    Stolnicu S; Park KJ; Kiyokawa T; Oliva E; McCluggage WG; Soslow RA
    Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S75-S91. PubMed ID: 33570865
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Usual-Type Endocervical Adenocarcinoma with a Microcystic, Elongated, and Fragmented Pattern of Stromal Invasion: A Case Report with Emphasis on Ki-67 Immunostaining and Targeted Sequencing Results.
    Choi S; Hwang S; Do SI; Kim HS
    Case Rep Oncol; 2020; 13(3):1421-1429. PubMed ID: 33442366
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion.
    Santoro A; Angelico G; Inzani F; Spadola S; Arciuolo D; Valente M; Musarra T; Capelli G; Fanfani F; Gallotta V; Scambia G; Zannoni GF
    Eur J Surg Oncol; 2021 Feb; 47(2):338-345. PubMed ID: 32788094
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
    Park KJ
    Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.
    Segura SE; Hoang L; Boros M; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA; Stolnicu S
    Int J Gynecol Pathol; 2020 Sep; 39(5):436-442. PubMed ID: 31517653
    [TBL] [Abstract][Full Text] [Related]  

  • 130. High Expression of Galectin-1, VEGF and Increased Microvessel Density Are Associated with MELF Pattern in Stage I-III Endometrioid Endometrial Adenocarcinoma.
    Zinovkin DA; Achinovich SL; Zubritskiy MG; Whatmore JL; Pranjol MZI
    J Pathol Transl Med; 2019 Sep; 53(5):280-288. PubMed ID: 31243940
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Serum deprivation-response protein regulates aldehyde dehydrogenase 1 through integrin-linked kinase signaling in endometrioid carcinoma cells.
    Tahara S; Nojima S; Ohshima K; Hori Y; Kurashige M; Wada N; Motoyama Y; Okuzaki D; Ikeda JI; Morii E
    Cancer Sci; 2019 May; 110(5):1804-1813. PubMed ID: 30907484
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Cervical Adenocarcinomas: A Heterogeneous Group of Tumors With Variable Etiologies and Clinical Outcomes.
    Hodgson A; Park KJ
    Arch Pathol Lab Med; 2019 Jan; 143(1):34-46. PubMed ID: 30785336
    [TBL] [Abstract][Full Text] [Related]  

  • 133. International Endocervical Adenocarcinoma Criteria and Classification: Validation and Interobserver Reproducibility.
    Hodgson A; Park KJ; Djordjevic B; Howitt BE; Nucci MR; Oliva E; Stolnicu S; Xu B; Soslow RA; Parra-Herran C
    Am J Surg Pathol; 2019 Jan; 43(1):75-83. PubMed ID: 29877920
    [TBL] [Abstract][Full Text] [Related]  

  • 134. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
    Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Genomic abnormalities in invasive endocervical adenocarcinoma correlate with pattern of invasion: biologic and clinical implications.
    Hodgson A; Amemiya Y; Seth A; Cesari M; Djordjevic B; Parra-Herran C
    Mod Pathol; 2017 Nov; 30(11):1633-1641. PubMed ID: 28731050
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
    Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
    Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
    Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 139. MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Sanci M; Güngördük K; Gülseren V; Karadeniz T; Kocaer M; Gungorduk O; Özdemir İA
    Int J Gynecol Pathol; 2018 Jan; 37(1):17-21. PubMed ID: 28319574
    [TBL] [Abstract][Full Text] [Related]  

  • 140. The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.
    Joehlin-Price AS; McHugh KE; Stephens JA; Li Z; Backes FJ; Cohn DE; Cohen DW; Suarez AA
    Am J Surg Pathol; 2017 Jan; 41(1):49-55. PubMed ID: 27740968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.